Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty

NCT01720108 is registered in ClinicalTrials.gov with David Anderson as lead sponsor.

NCT NCT01720108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01720108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty
Lead sponsor
David Anderson
Phase
Phase 3
Overall status
Completed
Start date
February 24, 2013
Completion date
July 31, 2016
Enrollment
3,426 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism